Matches in Wikidata for { <http://www.wikidata.org/entity/Q87709158> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q87709158 description "artículu científicu espublizáu en marzu de 2017" @default.
- Q87709158 description "scientific article published on 27 March 2017" @default.
- Q87709158 description "wetenschappelijk artikel" @default.
- Q87709158 description "наукова стаття, опублікована в березні 2017" @default.
- Q87709158 name "RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131-I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144-152" @default.
- Q87709158 name "RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131-I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144-152" @default.
- Q87709158 type Item @default.
- Q87709158 label "RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131-I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144-152" @default.
- Q87709158 label "RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131-I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144-152" @default.
- Q87709158 prefLabel "RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131-I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144-152" @default.
- Q87709158 prefLabel "RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131-I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144-152" @default.
- Q87709158 P1433 Q87709158-E00A0DD4-314A-47F5-B2E6-B406280EDB95 @default.
- Q87709158 P1476 Q87709158-2287EF01-B426-4C8D-BC04-98CBCB97796C @default.
- Q87709158 P2093 Q87709158-04D6282F-B0E5-429A-9F75-58079F0ECFB9 @default.
- Q87709158 P2093 Q87709158-6E2908A2-127D-4FCD-AEAD-388BCB648481 @default.
- Q87709158 P2093 Q87709158-8F3EA947-15E4-4BC8-AE92-365C9F731959 @default.
- Q87709158 P2093 Q87709158-A94C93C3-9D51-44A7-BF62-290D2F64E1B0 @default.
- Q87709158 P2093 Q87709158-ACDDFABA-A38A-4FAC-A05B-B92ED142C190 @default.
- Q87709158 P2093 Q87709158-B1ED1605-2D63-4D82-AC87-7C0F5C279C05 @default.
- Q87709158 P2093 Q87709158-D50621DF-3D0C-4587-934A-46AE0E597289 @default.
- Q87709158 P304 Q87709158-9E437568-F8CE-41DF-92FF-433CE6B991BB @default.
- Q87709158 P31 Q87709158-B1788038-3D35-4061-9006-EF596BA2608A @default.
- Q87709158 P356 Q87709158-BF6A24C7-9AED-400F-AB98-05A96452DE95 @default.
- Q87709158 P478 Q87709158-1A999146-6E0D-480B-A848-05AE8465F373 @default.
- Q87709158 P577 Q87709158-E35D7347-33B6-4672-BE92-8A7025605DDD @default.
- Q87709158 P698 Q87709158-3D6B0981-4742-4C7E-A6C0-7FEEF767A5C3 @default.
- Q87709158 P921 Q87709158-749E6573-6FA7-436B-AF02-4F726FCCE47F @default.
- Q87709158 P356 J.EJCA.2017.02.019 @default.
- Q87709158 P698 28359832 @default.
- Q87709158 P1433 Q332260 @default.
- Q87709158 P1476 "RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131-I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144-152" @default.
- Q87709158 P2093 "Cecile M Ronckers" @default.
- Q87709158 P2093 "Hanneke M van Santen" @default.
- Q87709158 P2093 "Jop Teepen" @default.
- Q87709158 P2093 "Leontine C M Kremer" @default.
- Q87709158 P2093 "Lieve Tytgat" @default.
- Q87709158 P2093 "Marry M van den Heuvel-Eibrink" @default.
- Q87709158 P2093 "Sarah Clement" @default.
- Q87709158 P304 "21-23" @default.
- Q87709158 P31 Q13442814 @default.
- Q87709158 P356 "10.1016/J.EJCA.2017.02.019" @default.
- Q87709158 P478 "77" @default.
- Q87709158 P577 "2017-03-27T00:00:00Z" @default.
- Q87709158 P698 "28359832" @default.
- Q87709158 P921 Q938205 @default.